Zinecard

Active Ingredient(s): Dexrazoxane
FDA Approved: * May 26, 1995
Pharm Company: * PHARMACIA AND UPJOHN
Category: Cancer

Dexrazoxane hydrochloride (Zinecard, Cardioxane) is a cardioprotective agent. It was discovered by Eugene Herman in 1972. The IV administration of dexrazoxane is in acidic condition with HCl adjusting the pH.[1] Contents 1 Uses 2 Mechanism 3 References 4 External links Uses Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of chemotherapeutic drugs such as anthracyclines,[2] such as daunorubicin or doxorubicin or other c... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zinecard 250 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0013-8717
Labeler:
Pharmacia and Upjohn Company
Zinecard 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0013-8727
Labeler:
Pharmacia and Upjohn Company

Related Brands

Drugs with the same active ingredients